AstraZeneca Can't Shed FCA Suit Over Seroquel 'Scheme'

By Jeff Overley · April 18, 2017, 5:23 PM EDT

A New York federal judge on Monday preserved a whistleblower's False Claims Act suit accusing AstraZeneca PLC of concealing safety information about antipsychotic drug Seroquel, finding plausible allegations of a "complex...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

United States of America et al v. Astrazeneca Biopharmaceuticals, Inc. et al

Case Number

1:14-cv-01718

Court

New York Eastern

Nature of Suit

Other Statutory Actions

Date Filed

March 17, 2014